Theriva Biologics and the Universitat Autònoma de Barcelona to receive a total of €2.28 Million to support the THERICEL project, a suspension cell platform for manufacturing viral-based therapies ...
ROCKVILLE, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”) a diversified clinical-stage company developing therapeutics designed to treat ...
Author Name Michela GIORCELLI (University of California) / HIGUCHI Yuki (Sophia University) / TAKAYASU Yutaro (University of Tokyo) / TANAKA Mari (Faculty Fellow, RIETI) In the aftermath of World War ...
Increased security incident workloads coupled with a shortage of skilled response experts are stretching many security operations centers (SOCs) to the breaking point. The fallout can lead to costly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback